Literature DB >> 11863365

Comparison of human chromosome 6p25 with mouse chromosome 13 reveals a greatly expanded ov-serpin gene repertoire in the mouse.

Dion Kaiserman1, Susan Knaggs, Katrina L Scarff, Anneliese Gillard, Ghazala Mirza, Matthew Cadman, Richard McKeone, Paul Denny, Jessica Cooley, Charaf Benarafa, Eileen Remold-O'Donnell, Jiannis Ragoussis, Phillip I Bird.   

Abstract

Ov-serpins are intracellular proteinase inhibitors implicated in the regulation of tumor progression, inflammation, and cell death. The 13 human ov-serpin genes are clustered at 6p25 (3 genes) and 18q21 (10 genes), and share common structures. We show here that a 1-Mb region on mouse chromosome 13 contains at least 15 ov-serpin genes compared with the three ov-serpin genes within 0.35 Mb at human 6p25 (SERPINB1 (MNEI), SERPINB6 (PI-6), SER-PINB9 (PI-9)). The mouse serpins have characteristics of functional inhibitors and fall into three groups on the basis of similarity to MNEI, PI-6, or PI-9. The genes map between the mouse orthologs of the Werner helicase interacting protein and NAD(P)H menadioine oxidoreductase 2 genes, in a region that contains the markers D13Mit136 and D13Mit116. They have the seven-exon structure typical of human 6p25 ov-serpin genes, with identical intron phasing. Most show restricted patterns of expression, with common sites of synthesis being the placenta and immune tissue. Compared with human, this larger mouse serpin repertoire probably reflects the need to regulate a larger proteinase repertoire arising from differing evolutionary pressures on the reproductive and immune systems.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11863365     DOI: 10.1006/geno.2002.6716

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  18 in total

1.  A genomic analysis of rat proteases and protease inhibitors.

Authors:  Xose S Puente; Carlos López-Otín
Journal:  Genome Res       Date:  2004-04       Impact factor: 9.043

2.  The major human and mouse granzymes are structurally and functionally divergent.

Authors:  Dion Kaiserman; Catherina H Bird; Jiuru Sun; Antony Matthews; Kheng Ung; James C Whisstock; Philip E Thompson; Joseph A Trapani; Phillip I Bird
Journal:  J Cell Biol       Date:  2006-11-20       Impact factor: 10.539

Review 3.  Serpins flex their muscle: I. Putting the clamps on proteolysis in diverse biological systems.

Authors:  Gary A Silverman; James C Whisstock; Stephen P Bottomley; James A Huntington; Dion Kaiserman; Cliff J Luke; Stephen C Pak; Jean-Marc Reichhart; Phillip I Bird
Journal:  J Biol Chem       Date:  2010-05-24       Impact factor: 5.157

Review 4.  Endolysosomal proteases and their inhibitors in immunity.

Authors:  Phillip I Bird; Joseph A Trapani; José A Villadangos
Journal:  Nat Rev Immunol       Date:  2009-12       Impact factor: 53.106

5.  Identification of Serpinb6b as a species-specific mouse granzyme A inhibitor suggests functional divergence between human and mouse granzyme A.

Authors:  Dion Kaiserman; Sarah E Stewart; Kim Plasman; Kris Gevaert; Petra Van Damme; Phillip I Bird
Journal:  J Biol Chem       Date:  2014-02-06       Impact factor: 5.157

6.  A pro-survival role for the intracellular granzyme B inhibitor Serpinb9 in natural killer cells during poxvirus infection.

Authors:  Matthew S Mangan; Carolina R Melo-Silva; Jennii Luu; Catherina H Bird; Aulikki Koskinen; Alexandra Rizzitelli; Monica Prakash; Katrina L Scarff; Arno Müllbacher; Matthias Regner; Phillip I Bird
Journal:  Immunol Cell Biol       Date:  2017-08-15       Impact factor: 5.126

Review 7.  Serpins, immunity and autoimmunity: old molecules, new functions.

Authors:  Mariele Gatto; Luca Iaccarino; Anna Ghirardello; Nicola Bassi; Patrizia Pontisso; Leonardo Punzi; Yehuda Shoenfeld; Andrea Doria
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

8.  The Caenorhabditis elegans muscle specific serpin, SRP-3, neutralizes chymotrypsin-like serine peptidases.

Authors:  Stephen C Pak; Christopher Tsu; Cliff J Luke; Yuko S Askew; Gary A Silverman
Journal:  Biochemistry       Date:  2006-04-11       Impact factor: 3.162

9.  Targeted disruption of SPI3/Serpinb6 does not result in developmental or growth defects, leukocyte dysfunction, or susceptibility to stroke.

Authors:  Katrina L Scarff; Kheng S Ung; Harshal Nandurkar; Peter J Crack; Catherina H Bird; Phillip I Bird
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

10.  Intrahepatic lymphocyte expression of dipeptidyl peptidase I-processed granzyme B and perforin induces hepatocyte expression of serine proteinase inhibitor 6 (Serpinb9/SPI-6).

Authors:  Heather W Stout-Delgado; Yonas Getachew; Bonnie C Miller; Dwain L Thiele
Journal:  J Immunol       Date:  2007-11-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.